G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
3 hedge funds and large institutions have $973K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$417K |
| 2 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$327K |
| 3 |
JP Morgan Chase
New York
|
+$218K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSA
1
Schonfeld Strategic Advisors
New York
| $422K | +$417K | +3,286 | New |
|
|
PVH
2
Psagot Value Holdings
Tel Aviv,
Israel
| $330K | +$327K | +2,571 | New |
|
|
3
JP Morgan Chase
New York
| $221K | +$218K | +1,719 | New |
|
GMVD Hedge Fund Activity: Q2 2021 in Review
3 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q2 2021, worth a combined $973K.
Buyers outnumbered sellers: 3 funds opened new GMVD positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $417K.
- 3 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $973K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q2 2021.
- 3 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q2 2021 and 0 closed out, a net change of +3 holders.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q2 2021 was Schonfeld Strategic Advisors, an estimated $417K added.
Based on aggregated 13F filings for Q2 2021.